1-cyclohexyl-2-(5H-imidazo(5,1-a)isoindol-5-yl)ethanol,
NLG919,
NLG919,
1402836-58-1,
1-cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanol,
NLG 919,
CHEMBL3629569,
1-Cyclohexyl-2-(5H-imidazo-[5,1-a]isoindol-5-yl)ethanol,
AK166956,
alpha-Cyclohexyl-5H-imidazo[5,1-a]isoindole-5-ethanol,
1-Cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethan-1-ol,
YTRRAUACYORZLX-UHFFFAOYSA-N,
GTPL9019,
SCHEMBL13280897,
DTXSID20735206,
EX-A574,
GDC0919,
HMS3653M05,
AOB87373,
GDC 0919,
NLG919(GDC-0919),
2588AH,
BDBM50126144,
MFCD26142661,
RG6078,
s7111,
AKOS025287054,
ACN-028914,
CS-3512,
SB16495,
KS-0000062W,
NCGC00386274-04,
AC-30124,
AS-35112,
BC600497,
DA-45347,
HY-13983,
QC-11707,
SC-95160,
FT-0700192,
SW219857-1,
J3.550.622E,
J-690162,
5H-Imidazo[5,1-a]isoindole-5-ethanol, alpha-cyclohexyl-,
1-cyclohexyl-2-[5H-imidazo[4,3-a]isoindol-5-yl]ethan-1-ol,
3-(2-Amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione hydrochloride,
Navoximod,
IDO-IN-7,
D06MHZ,
NLG-919,
GDC-0919,
C18H22N2O,
A4373,